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Melatonin receptors have been studied for several decades. The low expression of
the receptors in tissues led the scientific community to find a substitute for the
natural hormone melatonin, the agonist 2-[125I]-iodomelatonin. Using the agonist,
several hundreds of studies were conducted, including the discovery of agonists
and antagonists for the receptors and minute details about their molecular
behavior. Recently, we attempted to expand the panel of radioligands available for
studying the melatonin receptors by using the newly discovered compounds SD6,
DIV880, and S70254. These compounds were characterized for their affinities to
the hMT1 and hMT2 recombinant receptors and their functionality in the classical
GTPS system. SD6 is a full agonist, equilibrated between the receptor isoforms,
whereas S70254 and DIV880 are only partial MT2 agonists, with Ki in the low
nanomolar range while they have no affinity to MT1 receptors. These new tools will
hopefully allow for additions to the current body of information on the native
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